EUVIMEDEUVIMED entdecken
Übersichtsarbeit

CD48 as a Novel Target in Asthma Therapy

Ariel Munitz, Ido Bachelet, Francesca Levi-Schaffer

Recent Patents on Inflammation & Allergy Drug Discovery · 2007

DOI: 10.2174/187221307779815057 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Recent Patents on Inflammation & Allergy Drug Discovery, 2007. Verfasst von Ariel Munitz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Experimental Therapeutics, The School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusale…. Hauptthemen laut MEDLINE: Drug Delivery Systems. Die Arbeit wurde bisher 11-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD48, a CD2-related surface molecule, emerges as a critical effector molecule in immune responses. CD48 has a striking array of biological functions, among them adhesion, pathogen recognition, cellular activation, and cytokine regulation. Still, it is surprising that this mysterious molecule has not yet met its proper use as a therapeutical target in exaggerated immune disorders like hematopoietic tumors, autoimmunity and allergic reactions. Recently, CD48 was investigated in our laboratory as an effector molecule in human eosinophil function and in asthma. In this review, we shall discuss the known aspects of CD48 biology and describe the recent advances regarding the role of CD48 in human disease. Moreover, we shall review inventions making use of CD48, and discuss recent patents and the potential of CD48 as a future target for the therapy of allergic and other diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsAnimalsAntigens, CDAsthmaCD48 AntigenEosinophilsHumansImmune System DiseasesPatents as Topic

Substanzen

Antigens, CDCD48 AntigenCD48 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology & Experimental Therapeutics, The School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Zitieren

APA

Munitz, A., Bachelet, I., & Levi-Schaffer, F. (2007). CD48 as a Novel Target in Asthma Therapy. Recent Patents on Inflammation & Allergy Drug Discovery. https://doi.org/10.2174/187221307779815057

Vancouver

Munitz A, Bachelet I, Levi-Schaffer F. CD48 as a Novel Target in Asthma Therapy. Recent Patents on Inflammation & Allergy Drug Discovery. 2007. doi:10.2174/187221307779815057

BibTeX
@article{Munitz2007,
  author = {Munitz, Ariel and Bachelet, Ido and Levi-Schaffer, Francesca},
  title = {CD48 as a Novel Target in Asthma Therapy},
  journal = {Recent Patents on Inflammation & Allergy Drug Discovery},
  year = {2007},
  doi = {10.2174/187221307779815057}
}
Kostenlos starten →